Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study (REMI-PD)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cognitive impairment is common among non-demented individuals with Parkinson disease (PD) and is a significant source of disability and reduced quality of life. Unfortunately, there are no successful interventions to address these impairments. Prospective memory impairment is a particularly functionally- and clinically-relevant problem in PD. The investigator's project will determine if a targeted intervention strategy improves PD participants' prospective memory. The investigator's goal is to improve PD patients' everyday prospective memory so they can successfully perform desired activities and roles.
| Condition | Intervention |
|---|---|
|
Parkinson's Disease |
Behavioral: Prospective Memory Strategy |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Primary Purpose: Supportive Care |
| Official Title: | Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study |
| Estimated Enrollment: | 66 |
| Study Start Date: | June 2011 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
-
Behavioral: Prospective Memory Strategy
Cognitive impairment is common among non-demented individuals with Parkinson disease (PD) and is a significant source of disability and reduced quality of life. Unfortunately, there are no successful interventions to address these impairments. Prospective memory impairment is a particularly functionally- and clinically-relevant problem in PD. The investigator's project will determine if a targeted intervention strategy improves PD participants' prospective memory. The investigator will use a randomized controlled design and a laboratory-based assessment of prospective memory to test the effect of the strategy in a controlled environment. The investigator will also see if PD participants, with support from an occupational therapist (OT), can generalize the strategy to their complex, real-world environments and tasks. Our goal is to improve PD patients' everyday prospective memory so they can successfully perform desired activities and roles.
Eligibility| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Participants will be males and females over age 50 who meet criteria for idiopathic typical PD, are Hoehn & Yahr39 stage I-III (mild-moderate disease) and are treated with levodopa/carbidopa.
Exclusion Criteria:
- Possible dementia,
- treatment with certain medications that interfere with cognition (e.g., anticholinergics),
- change in medications over the study period, other neurological disorders, brain surgery (e.g., STN DBS),
- history of psychotic disorder or significant current psychiatric disorder, or any condition that would interfere with testing (e.g., vision problems).
Contacts and Locations| Contact: Tasha Doty, MA | 314-362-7160 | dotyt@npg.wustl.edu |
| Contact: Erin Foster, OTD, OTR/L | 314-286-1638 | erfoster@wustl.edu |
| United States, Missouri | |
| Washington University School of Medicine | Recruiting |
| St. Louis, Missouri, United States, 63110 | |
More Information
No publications provided
| Responsible Party: | Erin Foster, Assistant Professor of Occupational Therapy, Neurology and Psychiatry, Washington University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT01469741 History of Changes |
| Other Study ID Numbers: | 201103176 |
| Study First Received: | November 8, 2011 |
| Last Updated: | November 10, 2011 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on May 23, 2013